newsfilter
← Latest News
PR Newswire·

Oramed Reports Fiscal Third Quarter 2025 Financial Results

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP), a platform technology pioneer in the field of oral delivery solutions for drugs currently...